Purchase Order 36C25026P0343
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 23, awarded a delivery order valued at $9,454.29 to Diasorin Inc. on October 1, 2024, with an ultimate completion date of September 30, 2025. This delivery order, designated as Exercise OY2 for Fiscal Year 2025, was issued under a firm fixed-price arrangement with no set-aside designation. Diasorin Inc., a Minnesota-based subsidiary of Italian-owned Diasorin S.P.A., is a specialized medical diagnostics company that...
- Diasorin Inc., a Minnesota-based subsidiary of Italian diagnostics company Diasorin S.P.A., was awarded a delivery order valued at $104,110.78 by Veterans Integrated Service Network 10 on August 1, 2024, for consumable and reagents supporting LIAISON XL immunoassay analyzers. The contract, which operates under a firm fixed-price arrangement with no set-aside designation, will be performed in Stillwater, Minnesota, and is scheduled for completion by July 31, 2025. This delivery order procures...
- The Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9) awarded a $298,237 delivery order to Diasorin Inc. for reagents, testing, and equipment lease services. This firm fixed-price contract, effective through September 30, 2029, represents a continuation of the VA's long-standing relationship with Diasorin, a foreign-owned medical diagnostics subsidiary based in Stillwater, Minnesota. The award was not designated as a set-aside, reflecting Diasorin's competitive...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 10, awarded a $74,400 firm fixed-price purchase order to Diasorin Inc. on March 1, 2023, for hospital equipment service with an ultimate completion date of February 28, 2027. This contract represents a non-set-aside acquisition and is performed at the awardee's facility in Dayton, Ohio. Diasorin Inc., a Minnesota-based subsidiary of Italian-owned Diasorin S.P.A., is a specialized medical diagnostics company that...
- The Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a $229,166 firm fixed-price purchase order to Diasorin Inc. for the lease of a LIAISON XL analyzer, reagents, and preventative maintenance services. The award, issued December 1, 2021, with an ultimate completion date of November 30, 2026, represents a continuation of the VA's established relationship with Diasorin for advanced diagnostic laboratory equipment and supplies. Diasorin Inc., a Minnesota-based...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a purchase order valued at $299,978.74 to Diasorin Inc. for a DiaSorin immunochemistry analyzer with laboratory reagents and supplies. This contract represents a two-month extension to an existing arrangement and will be performed in Dallas, Texas, with an ultimate completion date of February 14, 2026. The contract employs firm fixed-price pricing and was awarded without any set-aside designation, reflecting...
- The Department of Veterans Affairs' Veterans Integrated Service Network 23 awarded a delivery order valued at $13,294.80 to Diasorin Inc. on October 1, 2024, with completion targeted for September 30, 2025. This firm fixed-price delivery order represents Exercise OY2 of a fiscal year 2025 task order, procured without set-aside designation. Diasorin Inc., a Stillwater, Minnesota-based subsidiary of Italian parent company Diasorin S.P.A., is a specialized medical diagnostics supplier that provides...
- Diasorin Inc., a Minnesota-based medical diagnostics company and subsidiary of Italian firm Diasorin S.P.A., was awarded a $89,667.50 firm fixed-price delivery order by Veterans Integrated Service Network 5 for the LIAISON XL Analyzer on April 11, 2025, with an ultimate completion date of August 1, 2025. The contract, which includes de-obligation of excess funds, will be performed in Stillwater, Minnesota, and carries no socioeconomic set-aside designation. This delivery order is issued...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8) awarded a $264,577.30 firm fixed-price purchase order to Diasorin Inc. for immunochemistry/liaison XS analyzer equipment and reagents, with performance extending through December 31, 2028. The contract, awarded January 1, 2024, will be performed at a facility in Riviera Beach, Florida and carries no small business set-aside designation. Diasorin Inc., a Minnesota-based subsidiary of Italian-owned Diasorin...
- The Department of Veterans Affairs, Veterans Integrated Service Network 19, awarded a $60,819.40 delivery order to Diasorin Inc. on June 15, 2023, for the purchase of LIAISON XS chemiluminescence immunoassay analyzers to support the VA's regional medical facilities in Stillwater, Minnesota. The contract represents a firm fixed-price delivery order with an ultimate completion date of June 14, 2024, and was issued without socioeconomic set-aside designation. Diasorin Inc., a Minnesota-based...
The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 10, awarded a $70,426.78 firm fixed-price purchase order to Diasorin Inc. for DiaSorin XL reagents on March 1, 2026, with performance completion scheduled for August 31, 2026. The award carries no set-aside designation and represents a direct procurement of diagnostic reagent supplies for use at VA healthcare facilities served by VISN 10 in the Minneapolis-Saint Paul region, where the contractor's place of performance is located in Stillwater, Minnesota. Diasorin Inc., a Minnesota-based subsidiary of Italian parent company Diasorin S.P.A., is a specialized medical diagnostics firm that manufactures chemiluminescence immunoassay analyzers and related consumables for federal healthcare agencies. This purchase order draws from Diasorin Inc.'s substantial existing contract portfolio with the VA, which includes a $10 million Federal Supply Schedule contract (FSS-66-III) for critical laboratory analyzer services through March 2030 and multiple single-award Indefinite Delivery Contracts with various VA VISNs valued between $1.5 million and $2 million. The company performs as a prime contractor without subcontractors and has established itself as a key supplier of infectious disease diagnostic solutions across the federal healthcare system, with prior awards from the Defense Health Agency, Centers for Disease Control and Prevention, and other federal medical entities. The reagent procurement supports ongoing laboratory diagnostic capabilities for conditions including COVID-19, tuberculosis, and other critical infectious diseases across the VA's VISN 10 medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $70.4k | 3/9/26 |